201 related articles for article (PubMed ID: 30126341)
1. Glycan binding and specificity of viral influenza neuraminidases by classical molecular dynamics and replica exchange molecular dynamics simulations.
Phanich J; Threeracheep S; Kungwan N; Rungrotmongkol T; Hannongbua S
J Biomol Struct Dyn; 2019 Aug; 37(13):3354-3365. PubMed ID: 30126341
[TBL] [Abstract][Full Text] [Related]
2. Substrate Binding by the Second Sialic Acid-Binding Site of Influenza A Virus N1 Neuraminidase Contributes to Enzymatic Activity.
Du W; Dai M; Li Z; Boons GJ; Peeters B; van Kuppeveld FJM; de Vries E; de Haan CAM
J Virol; 2018 Oct; 92(20):. PubMed ID: 30089692
[TBL] [Abstract][Full Text] [Related]
3. Nuclear Magnetic Resonance and Molecular Dynamics Simulation of the Interaction between Recognition Protein H7 of the Novel Influenza Virus H7N9 and Glycan Cell Surface Receptors.
Macchi E; Rudd TR; Raman R; Sasisekharan R; Yates EA; Naggi A; Guerrini M; Elli S
Biochemistry; 2016 Dec; 55(48):6605-6616. PubMed ID: 27933797
[TBL] [Abstract][Full Text] [Related]
4. Mutation of the Second Sialic Acid-Binding Site, Resulting in Reduced Neuraminidase Activity, Preceded the Emergence of H7N9 Influenza A Virus.
Dai M; McBride R; Dortmans JCFM; Peng W; Bakkers MJG; de Groot RJ; van Kuppeveld FJM; Paulson JC; de Vries E; de Haan CAM
J Virol; 2017 May; 91(9):. PubMed ID: 28202753
[TBL] [Abstract][Full Text] [Related]
5. The binding properties of the H5N1 influenza virus neuraminidase as inferred from molecular modeling.
Raab M; Tvaroška I
J Mol Model; 2011 Jun; 17(6):1445-56. PubMed ID: 20853123
[TBL] [Abstract][Full Text] [Related]
6. A mutant influenza virus that uses an N1 neuraminidase as the receptor-binding protein.
Hooper KA; Bloom JD
J Virol; 2013 Dec; 87(23):12531-40. PubMed ID: 24027333
[TBL] [Abstract][Full Text] [Related]
7. The 2nd sialic acid-binding site of influenza A virus neuraminidase is an important determinant of the hemagglutinin-neuraminidase-receptor balance.
Du W; Guo H; Nijman VS; Doedt J; van der Vries E; van der Lee J; Li Z; Boons GJ; van Kuppeveld FJM; de Vries E; Matrosovich M; de Haan CAM
PLoS Pathog; 2019 Jun; 15(6):e1007860. PubMed ID: 31181126
[TBL] [Abstract][Full Text] [Related]
8. Investigation of the binding and cleavage characteristics of N1 neuraminidases from avian, seasonal, and pandemic influenza viruses using saturation transfer difference nuclear magnetic resonance.
Garcia JM; Lai JC; Haselhorst T; Choy KT; Yen HL; Peiris JS; von Itzstein M; Nicholls JM
Influenza Other Respir Viruses; 2014 Mar; 8(2):235-42. PubMed ID: 24118862
[TBL] [Abstract][Full Text] [Related]
9. MD simulation of the interaction between sialoglycans and the second sialic acid binding site of influenza A virus N1 neuraminidase.
Elli S; Gambacorta N; Rudd TR; Matrosovich M; Guerrini M
Biochem J; 2021 Jan; 478(2):423-441. PubMed ID: 33410905
[TBL] [Abstract][Full Text] [Related]
10. N-Linked Glycan Sites on the Influenza A Virus Neuraminidase Head Domain Are Required for Efficient Viral Incorporation and Replication.
Östbye H; Gao J; Martinez MR; Wang H; de Gier JW; Daniels R
J Virol; 2020 Sep; 94(19):. PubMed ID: 32699088
[TBL] [Abstract][Full Text] [Related]
11. Characterization of pseudoparticles paired with hemagglutinin and neuraminidase from highly pathogenic H5N1 influenza and avian influenza A (H7N9) viruses.
Zhang F; Wang S; Wang Y; Shang X; Zhou H; Cai L
Virus Res; 2018 Jul; 253():20-27. PubMed ID: 29859234
[TBL] [Abstract][Full Text] [Related]
12. Receptor recognition mechanism of human influenza A H1N1 (1918), avian influenza A H5N1 (2004), and pandemic H1N1 (2009) neuraminidase.
Jongkon N; Sangma C
J Mol Model; 2012 Jan; 18(1):285-93. PubMed ID: 21523534
[TBL] [Abstract][Full Text] [Related]
13. Influenza viruses with receptor-binding N1 neuraminidases occur sporadically in several lineages and show no attenuation in cell culture or mice.
Hooper KA; Crowe JE; Bloom JD
J Virol; 2015 Apr; 89(7):3737-45. PubMed ID: 25609803
[TBL] [Abstract][Full Text] [Related]
14. Enhanced Human-Type Receptor Binding by Ferret-Transmissible H5N1 with a K193T Mutation.
Peng W; Bouwman KM; McBride R; Grant OC; Woods RJ; Verheije MH; Paulson JC; de Vries RP
J Virol; 2018 May; 92(10):. PubMed ID: 29491160
[TBL] [Abstract][Full Text] [Related]
15. Mutation-induced loop opening and energetics for binding of tamiflu to influenza N8 neuraminidase.
Kar P; Knecht V
J Phys Chem B; 2012 May; 116(21):6137-49. PubMed ID: 22553951
[TBL] [Abstract][Full Text] [Related]
16. Influenza virus neuraminidases with reduced enzymatic activity that avidly bind sialic Acid receptors.
Zhu X; McBride R; Nycholat CM; Yu W; Paulson JC; Wilson IA
J Virol; 2012 Dec; 86(24):13371-83. PubMed ID: 23015718
[TBL] [Abstract][Full Text] [Related]
17. Insights into the human glycan receptor conformation of 1918 pandemic hemagglutinin-glycan complexes derived from nuclear magnetic resonance and molecular dynamics studies.
Elli S; Macchi E; Rudd TR; Raman R; Sassaki G; Viswanathan K; Yates EA; Shriver Z; Naggi A; Torri G; Sasisekharan R; Guerrini M
Biochemistry; 2014 Jul; 53(25):4122-35. PubMed ID: 24878075
[TBL] [Abstract][Full Text] [Related]
18. Molecular dynamics simulation of the effects of single (S221P) and double (S221P and K216E) mutations in the hemagglutinin protein of influenza A H5N1 virus: a study on host receptor specificity.
Behera AK; Chandra I; Cherian SS
J Biomol Struct Dyn; 2016 Sep; 34(9):2054-67. PubMed ID: 26457729
[TBL] [Abstract][Full Text] [Related]
19. Recent H3N2 Viruses Have Evolved Specificity for Extended, Branched Human-type Receptors, Conferring Potential for Increased Avidity.
Peng W; de Vries RP; Grant OC; Thompson AJ; McBride R; Tsogtbaatar B; Lee PS; Razi N; Wilson IA; Woods RJ; Paulson JC
Cell Host Microbe; 2017 Jan; 21(1):23-34. PubMed ID: 28017661
[TBL] [Abstract][Full Text] [Related]
20. Free energy simulations reveal a double mutant avian H5N1 virus hemagglutinin with altered receptor binding specificity.
Das P; Li J; Royyuru AK; Zhou R
J Comput Chem; 2009 Aug; 30(11):1654-63. PubMed ID: 19399777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
